Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 143

1.

Protecting infants against pertussis: the cocooning strategy in practice.

Carrico CA, O'Keefe C.

Nurse Pract. 2013 Mar 10;38(3):40-5. doi: 10.1097/01.NPR.0000426408.54853.2b.

PMID:
23416340
2.

Pregnancy dose Tdap and postpartum cocooning to prevent infant pertussis: a decision analysis.

Terranella A, Asay GR, Messonnier ML, Clark TA, Liang JL.

Pediatrics. 2013 Jun;131(6):e1748-56. doi: 10.1542/peds.2012-3144. Epub 2013 May 27.

3.

Implementation of cocooning against pertussis in a high-risk population.

Healy CM, Rench MA, Baker CJ.

Clin Infect Dis. 2011 Jan 15;52(2):157-62. doi: 10.1093/cid/ciq001.

PMID:
21288837
4.

Cocooning: a concept to protect young children from infectious diseases.

Grizas AP, Camenga D, Vázquez M.

Curr Opin Pediatr. 2012 Feb;24(1):92-7. doi: 10.1097/MOP.0b013e32834e8fe9. Review.

PMID:
22157361
7.

Effectiveness of Prenatal Versus Postpartum Tetanus, Diphtheria, and Acellular Pertussis Vaccination in Preventing Infant Pertussis.

Winter K, Nickell S, Powell M, Harriman K.

Clin Infect Dis. 2017 Jan 1;64(1):3-8. Epub 2016 Sep 13.

PMID:
27624955
8.

Infant pertussis epidemiology and implications for tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccination: King County, Washington, 2002 through 2007.

Hanson MP, Kwan-Gett TS, Baer A, Rietberg K, Ohrt M, Duchin JS.

Arch Pediatr Adolesc Med. 2011 Jul;165(7):647-52. doi: 10.1001/archpediatrics.2011.85.

PMID:
21727277
9.

Prevention of pertussis among adolescents: recommendations for use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccine.

America Academy of Pediatrics Commitee on Infectious Diseases.

Pediatrics. 2006 Mar;117(3):965-78. Epub 2005 Dec 28.

PMID:
16382131
10.

Evaluation of the impact of a pertussis cocooning program on infant pertussis infection.

Healy CM, Rench MA, Wootton SH, Castagnini LA.

Pediatr Infect Dis J. 2015 Jan;34(1):22-6. doi: 10.1097/INF.0000000000000486.

PMID:
24992123
11.

Pertussis in adolescents and adults: should we vaccinate?

Lee GM, Lebaron C, Murphy TV, Lett S, Schauer S, Lieu TA.

Pediatrics. 2005 Jun;115(6):1675-84.

PMID:
15930232
12.

Tetanus-diphtheria-acellular pertussis vaccination of adults in the USA.

Gidengil CA, Sandora TJ, Lee GM.

Expert Rev Vaccines. 2008 Jul;7(5):621-34. doi: 10.1586/14760584.7.5.621. Review.

PMID:
18564017
13.
14.

Impact of maternal postpartum tetanus and diphtheria toxoids and acellular pertussis immunization on infant pertussis infection.

Castagnini LA, Healy CM, Rench MA, Wootton SH, Munoz FM, Baker CJ.

Clin Infect Dis. 2012 Jan 1;54(1):78-84. doi: 10.1093/cid/cir765. Epub 2011 Nov 10.

PMID:
22075790
15.

Tdap vaccination during pregnancy to reduce pertussis infection in young infants.

Matlow JN, Pupco A, Bozzo P, Koren G.

Can Fam Physician. 2013 May;59(5):497-8.

16.

Acellular pertussis vaccine use in risk groups (adolescents, pregnant women, newborns and health care workers): a review of evidences and recommendations.

Bechini A, Tiscione E, Boccalini S, Levi M, Bonanni P.

Vaccine. 2012 Jul 27;30(35):5179-90. doi: 10.1016/j.vaccine.2012.06.005. Epub 2012 Jun 15. Review.

PMID:
22709953
18.

Factors associated with the intention to recommend pertussis vaccination for postpartum women: a survey in Taiwan of obstetrician-gynecologists' knowledge, beliefs, and attitudes.

Kao CC, Huang SY, Cheng PJ, Shaw SW, Chueh HY, Chang SD, Hsu TY, Kung FT, Hsieh TT.

Taiwan J Obstet Gynecol. 2012 Jun;51(2):222-8. doi: 10.1016/j.tjog.2012.04.010.

20.

Association of postpartum maternal tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine administration and timeliness of infant immunization.

Kaur I, George KJ, Pena-Ricardo C, Kelly BA, Watson B.

Pediatr Infect Dis J. 2013 Nov;32(11):1287-9. doi: 10.1097/INF.0b013e31829b9ff0.

PMID:
23694833

Supplemental Content

Support Center